Their enzymatic hydrolysates obtained by Alcalase 2.4 L could be exploited as a new source of ACE inhibitory peptides and be incorporated as functional ingredients in nutraceuticals and pharmaceuticals due to their effectiveness in both the prevention and treatment of hypertension (regulating normal blood pressure in hypertensive humans). This evidence concerns the gene ACE and hypertensive disorder.